No Data
No Data
No Data
No Data
No Data
Abpro Announces Filing of Registration Statement on Form S-4 in Connection With Business Combination Agreement With Atlantic Coastal Acquisition Corp. II
WOBURN, Mass. and NEW YORK, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Abpro Corporation ("Abpro"), a biotech company with the mission of improving the lives of mankind facing severe and life-threatening diseases with
GlobeNewswireJan 22 21:00
Atlantic Coastal Acqn II Extends Period to Complete Business Combination to Nov 19 >ACAB
Atlantic Coastal Acqn II Extends Period to Complete Business Combination to Nov 19 >ACAB
Dow JonesOct 19, 2023 04:20
Atlantic Coastal Acqn II Sponsor Deposited $80,000 Into Trust Account >ACAB
Atlantic Coastal Acqn II Sponsor Deposited $80,000 Into Trust Account >ACAB
Dow JonesOct 19, 2023 04:20
Atlantic Coastal Acquisition Corp. II Announces Extension of Business Combination Period and Additional Contribution to Trust Account
Atlantic Coastal Acquisition Corp. II (NASDAQ: ACAB) (the "Company"), a special purpose acquisition corporation, announced that Atlantic Coastal...
PR NewswireOct 19, 2023 04:15
Biotechnology Company Abpro to Merge With SPAC Atlantic Coastal Acquisition
Seeking AlphaSep 22, 2023 04:14
Abpro to Become Publicly Traded via Merger With Atlantic Coastal Acquisition Corp. II
Abpro is a biotechnology company specializing in the development of next-generation antibody therapies intended to improve the lives of those with life-threatening diseases. The transaction values Abpro at $725
BusinesswireSep 22, 2023 04:00
No Data
No Data